Table 1 Clinical characteristics of patients

From: Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer

Title

Name

Experimental group (n = 41)

Control group (n = 41)

X2/t

P

Gender

Male

18 (43.90)

13 (31.71)

1.297

0.255

Female

23 (56.10)

28 (68.29)

Age (years)

 

48.69 ± 4.27

48.96 ± 4.31

0.285

0.776

Smoking history

None

30 (73.17)

36 (87.80)

2.795

0.095

Yes

11 (26.83)

5 (12.20)

History of alcoholism

None

33 (80.49)

34 (82.93)

0.082

0.775

 

Yes

8 (19.51)

7 (17.07)

Family history

None

31 (75.61)

32 (78.05)

0.069

0.794

Yes

10 (24.39)

9 (21.95)

Degree of education

Primary and junior high school

26 (63.41)

15 (36.58)

0.205

0.651

Senior high school and above

24 (58.54)

17 (41.46)